CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
68,85 €
1,51 %
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $88.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Piper Sandler from $93.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Mizuho from $86.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $66.00 price target on the stock, down previously from $90.00.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $85.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Bank of America Co. from $95.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Argus from $100.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at JPMorgan Chase & Co. from $101.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Evercore ISI from $65.00 to $62.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $68.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $85.00 price target on the stock, up previously from $59.00.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Evercore ISI from $62.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $82.00 price target on the stock, up previously from $63.00.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Truist Financial Co. from $66.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Barclays PLC from $82.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Mizuho from $73.00 to $66.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Northrop Grumman Corp. diskutieren